DOSTRIL

This brand name is authorized in Nigeria.

Active ingredients

The drug DOSTRIL contains one active pharmaceutical ingredient (API):

1	Lisinopril UNII E7199S1YWR - LISINOPRIL
	Lisinopril is a peptidyl dipeptidase inhibitor. It inhibits the angiotensin-converting enzyme (ACE) that catalyses the conversion of angiotensin I to the vasoconstrictor peptide, angiotensin II. Angiotensin II also stimulates aldosterone secretion by the adrenal cortex. Inhibition of ACE results in decreased concentrations of angiotensin II which results in decreased vasopressor activity and reduced aldosterone secretion.
	Read more about Lisinopril

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7709	Tablet	DOSTRIL 10 TABLETS TAB 10 mg 2X14	29 CMS-PP-352630 DOSTRIL 10 TABLETS LISINOPRIL BP 10MG EACH TABLET CONTAINS LISINOPRIL DIHYDRATE EQ TO LISINOPRIL BP 10MG Calcium Hydrogen Phosphate BP, Mannitol BP, Pregelatinised Starch BP , Croscarmellose Sodium BP, Purified Water USP, Magnesium Stearate BP B4-7709 Drugs Imported Products 2X14 Prescription Only Medicine (POM) 9/3/2023 DONY-TRIUMPH AND COMPANY NIGERIA LIMITED, I/I J POND STREET,HOUSING ESTATE FEGGE ONITSHA ANAMBRA STATE 80868969 donytrump15@yahoo.com BAFNA PHARMA LIMITED, 147 MADHAVARAM RED HILLS ROAD GRANTLYON VILLAGE VADAKARI CHENNAI TAMIL, NADU INDIA, India	31/10/2023
C4-0031	Tablet	DOSTRIL 5 TABLETS TAB 5 mg 2X14	30 CMS-PP-352288 DOSTRIL 5 TABLETS LISINOPRIL USP 5MG CONTAINS LISINOPRIL DIHYDRATE USP 5MG Calcium Hydrogen Phosphate BP, Mannitol BP, Pregelatinised Starch BP , Croscarmellose Sodium BP, Purified Water USP, Magnesium Stearate BP. C4-0031 Drugs Imported Products 2X14 Prescription Only Medicine (POM) 9/3/2023 DONY-TRIUMPH AND COMPANY NIGERIA LIMITED, I/I J POND STREET,HOUSING ESTATE FEGGE ONITSHA ANAMBRA STATE 80868969 donytrump15@yahoo.com BAFNA PHARM LTD, NO 147, MADHAVARAM REDHILLS HIGH ROAD, GRANTLYON VILL, VADAKARI POST CHENNAI, INDIA, India	31/10/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09AA03	Lisinopril	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09A ACE inhibitors, plain → C09AA ACE inhibitors, plain
Discover more medicines within C09AA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7709, C4-0031